#2;3-O-[BETA-D-GLUCOPYRANOSYL-(1->3)-[ALPHA-L-ARABINOFURANOSYL-(1->4)]-BETA-D-GLUCURONOPYRANOSYL]-OLEAN-11,13(18)-DIENE-28-OIC-ACID-28-O-BETA-D-GLUCOPYRANOSYLE
Compound with spectra: 1 NMR
![#2;3-O-[BETA-D-GLUCOPYRANOSYL-(1->3)-[ALPHA-L-ARABINOFURANOSYL-(1->4)]-BETA-D-GLUCURONOPYRANOSYL]-OLEAN-11,13(18)-DIENE-28-OIC-ACID-28-O-BETA-D-GLUCOPYRANOSYLE](/api/compound/F7bOuOiHWCL.png?ph=true&h=300&w=458 "#2;3-O-[BETA-D-GLUCOPYRANOSYL-(1->3)-[ALPHA-L-ARABINOFURANOSYL-(1->4)]-BETA-D-GLUCURONOPYRANOSYL]-OLEAN-11,13(18)-DIENE-28-OIC-ACID-28-O-BETA-D-GLUCOPYRANOSYLE")
| SpectraBase Compound ID | F7bOuOiHWCL |
|---|---|
| InChI | InChI=1S/C53H82O23/c1-48(2)14-16-53(47(68)76-45-37(64)34(61)31(58)25(20-55)71-45)17-15-51(6)22(23(53)18-48)8-9-28-50(5)12-11-29(49(3,4)27(50)10-13-52(28,51)7)72-46-38(65)39(73-44-36(63)33(60)30(57)24(19-54)69-44)40(41(75-46)42(66)67)74-43-35(62)32(59)26(21-56)70-43/h8-9,24-41,43-46,54-65H,10-21H2,1-7H3,(H,66,67)/t24-,25+,26+,27-,28+,29-,30-,31+,32+,33+,34-,35-,36-,37+,38+,39+,40-,41-,43+,44+,45-,46+,50-,51+,52+,53-/m0/s1 |
| InChIKey | OYLLTTYNBRSYRY-HVBGRYEUSA-N |
| Mol Weight | 1087.2 g/mol |
| Molecular Formula | C53H82O23 |
| Exact Mass | 1086.524689 g/mol |
| Enantiomer InChIKey | OYLLTTYNBRSYRY-PZVJKJGQSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C5D5N |
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
41,42,43,44,45,46,47,48-Octamethoxy-4,9,14,19,24,29,34,39-octamethylnonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
Quamoclin I peracetate [(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
41,42,43,44,45,46,47,48-Octamethoxynonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
[(3aS,6R,7aR)-Hexahydro-8,8-dimethyl-1-{[(2'R,3S)'-(4"-methoxy-2',3',6'-trimethylphenylsulfonyl)-2'-methylspiro[3H-indle-3,3'-pyrrolidin]-2'-yl}carbonyl-3H,3a,6-methano-2,1-benzisothiazole 2,2-dioxide
Quamoclin II peracetate[(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
tetramethyl (2.alpha.,3.alpha.,6.beta.,8.beta.,10.beta.,12.beta.,15.alpha.,16.alpha.)-19-endo,23-endo,27-exo-9,21-dioxo-7,11,19,23,27,28-hexaoxaundecacyclo[15.7.2.1(2,16),1(4,14).0(1,17).0(3,15).0(5,13).0(6,8).0(10,12).0(18,20).0(22,24)]octacosa-5(13),25-diene-3,15,25,26-tetracarboxylate
38-(3,5-Dimethylphenyl)-7,8,19,20,28,29,35,36-octahydro-6H,10H,16H,32H,34H-59:17,21-dimethano-11,15-metheno-1,2,5-[1',3']pyrimidino-5H,27H-dibenzo[b,u][1,23,4,8,16,20]dioxatetraazacyclohexacosine-32,37,39-trione
38-(3,5-Dimethylphenyl)-7,8,19,20,28,29,35,36-octahydro-6H,10H,16H,32H,34H-59:17,21-dimethano-11,15-metheno-1,2,5-[1',3']pyrimidino-5H,27H-dibenzo[b,u][1,23,4,8,16,20]dioxatetraazcyclohexacosine-32,37,39-trione
| Title | Journal or Book | Year |
|---|---|---|
| New antioxidant and antiglycation active triterpenoid saponins from the root bark of Aralia taibaiensis | Fitoterapia | 2012 |